Document is current
Any future updates will be listed below
-
Authors
Felsheim, Brooke M. https://orcid.org/0000-0001-8421-8290
Fernandez-Martinez, Aranzazu
Fan, Cheng
Pfefferle, Adam D. https://orcid.org/0000-0002-4924-1767
Hayward, Michele C.
Hoadley, Katherine A. https://orcid.org/0000-0002-1216-477X
Rashid, Naim U.
Tolaney, Sara M. https://orcid.org/0000-0002-5940-8671
Somlo, George
Carey, Lisa A. https://orcid.org/0000-0003-2388-4649
Sikov, William M.
Perou, Charles M. https://orcid.org/0000-0001-9827-2247
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50-CA058223, R01-CA14876, U10CA180821, U10CA180882, U24CA176171, U10CA180821, U10CA180882, U24CA176171, U10CA180821, U10CA180882, U24CA176171, U10CA180821, U10CA180882, U24CA176171)
Breast Cancer Research Foundation (BCRF-23-127)
Susan G. Komen (SAC-160074)
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 25 February 2025
First Online: 8 March 2025
Competing interests
: C.M.P. is an equity stockholder and consultant of BioClassifier LLC; C.M.P. is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay. S.M.T. reports: Consulting or Advisory Role: Novartis, Pfizer/SeaGen, Merck, Eli Lilly, AstraZeneca, Genentech/Roche, Eisai, Sanofi, Bristol Myers Squibb/Systimmune, Daiichi Sankyo, Gilead, Zymeworks, Zentalis, Blueprint Medicines, Reveal Genomics, Sumitovant Biopharma, Artios Pharma, Menarini/Stemline, Aadi Bio, Bayer, Incyte Corp, Jazz Pharmaceuticals, Natera, Tango Therapeutics, eFFECTOR, Hengrui USA, Cullinan Oncology, Circle Pharma, Arvinas, BioNTech, Launch Therapeutics, Zuellig Pharma, Johnson&Johnson/Ambrx. Research Funding: Genentech/Roche, Merck, Exelixis, Pfizer, Lilly, Novartis, Bristol Myers Squibb, AstraZeneca, NanoString Technologies, Gilead, SeaGen, OncoPep, Daiichi Sankyo, Menarini/Stemline. Travel: Lilly, Sanofi, Gilead, Jazz, Pfizer, Arvinas. W.M.S. is an unpaid member of the steering committee for AbbVie.
